---
title: "Beyond Amyloid and Tau: Defining the Next Era of Neurodegenerative Disease Biomarkers"
description: "Beyond Amyloid and Tau: Defining the Next Era of Neurodegenerative Disease Biomarkers"
---

[![Olink-logo-white-1](https://info.olink.com/hs-fs/hubfs/Imported%20images/Olink-logo-white-1.png?width=67&height=30&name=Olink-logo-white-1.png "Olink-logo-white-1")](https://olink.com)

## ROUNDTABLE - Beyond Amyloid and Tau: Defining the Next Era of Neurodegenerative Disease Biomarkers

 ON DEMAND

[Watch now](https://info.olink.com/neuro-roundtable-2026#CTASection)

### Where is neurodegenerative biomarker research heading next?

Amyloid and tau biomarkers have transformed Alzheimer's disease research, enabling biological diagnosis, earlier detection, and therapeutic progress. But what comes next?

Hear from experts spanning clinical research and biopharma as they discuss the discoveries, challenges, and opportunities that will shape the next generation of biomarkers—from Alzheimer's disease to the broader neurodegenerative landscape.

 

#### Featured speakers:

![Henrik Zetterber-1](https://7074596.fs1.hubspotusercontent-na1.net/hub/7074596/hubfs/Henrik%20Zetterber-1.png?width=1200&length=1200&name=Henrik%20Zetterber-1.png)

Henrik Zetterberg, MD, PhD

Professor of Neurochemistry, University College London (UCL) and the University of Gothenburg

![Pallavi-Sachdev](https://7074596.fs1.hubspotusercontent-na1.net/hub/7074596/hubfs/Pallavi-Sachdev.png?width=1200&length=1200&name=Pallavi-Sachdev.png)

Pallavi Sachdev, MPH, PhD 

Vice President & Head, Translational Science, Eisai

![Dr-Nicholas-Ashton-2-modified-1](https://7074596.fs1.hubspotusercontent-na1.net/hub/7074596/hubfs/Dr-Nicholas-Ashton-2-modified-1.png?width=1200&length=1200&name=Dr-Nicholas-Ashton-2-modified-1.png)

Nicholas Ashton, PhD

Senior Director, Biomarker Program at Banner Health; Associate Professor at the University of Gothenburg 

![Marta Del Campo-1](https://7074596.fs1.hubspotusercontent-na1.net/hub/7074596/hubfs/Marta%20Del%20Campo-1.png?width=1200&length=1200&name=Marta%20Del%20Campo-1.png)

Marta Del Campo, PhD

Head of Fluid Biomarkers Facility  
Barcelonaβeta Brain Research Center (BBRC)

![KellyMiller-modified-1](https://7074596.fs1.hubspotusercontent-na1.net/hub/7074596/hubfs/KellyMiller-modified-1.png?width=1200&length=1200&name=KellyMiller-modified-1.png)

Kelly Miller, PhD

Sr. Director, Head of Global Marketing, Olink, part of Thermo Fisher Scientific 

#### Access this though-provoking on-demand discussion now!

 Hear from experts Henrik Zetterberg, Nicholas Ashton, Pallavi Sachdev and Marta Del Campo!

Watch the complete discussion

#### Register below to recieve the on-demand discussion.

<iframe data-hsv-src="https://play.hubspotvideo.com/v/7074596/id/217039362922?play_button_color=ffffff" referrerpolicy="origin" sandbox="allow-forms allow-scripts allow-same-origin allow-popups" allow="autoplay; fullscreen;" style="position: absolute !important; width: 100% !important; height: 100% !important; left: 0; top: 0; border: 0 none; pointer-events: initial" title="HubSpot Video" loading="lazy" data-hsv-id="217039362922" data-hsv-play-button-color="ffffff" data-hsv-width="1920" data-hsv-height="1080" data-hsv-full-width="true"></iframe>

#### Access the full discussion now!

REGISTER NOW

#### Register below to recieve the on-demand discussion.

#### Watch the highlights

Watch a preview of the conversation as the panel challenges current thinking and explores the scientific questions that will define the next generation of neurodegenerative disease biomarkers.

#### What you will learn:

- Why biomarker discovery is still in its infancy
- Where the biggest opportunities lie beyond amyloid and tau
- What it will take to build biomarkers that predict progression and treatment response
- Why biomarker signatures—not single analytes—may underpin the future of precision neurology
- The scientific and translational challenges that must be solved to bring the next generation of biomarkers into clinical practice

 

© 2026 Olink Proteomics AB, part of Thermo Fisher Scientific. Olink products and services are For Research Use Only. Not for use in diagnostic procedures.

```json
{
  "@context" : "https://schema.org",
  "@type" : "VideoObject",
  "caption" : {
    "@type" : "MediaObject",
    "contentUrl" : "https://info.olink.com/media-transcripts/217046771333/en.vtt",
    "inLanguage" : "en",
    "name" : "en Captions"
  },
  "contentUrl" : "https://7074596.fs1.hubspotusercontent-na1.net/hubfs/7074596/video_assets/217046771333/inherited/web_optimized.mp4",
  "dateModified" : "2026-07-29T22:31:53.637Z",
  "duration" : "PT1M25.035S",
  "height" : 1080,
  "name" : "AAIC Highlights",
  "thumbnailUrl" : "https://7074596.fs1.hubspotusercontent-na1.net/hubfs/7074596/AAIC%20Highlights.mp4/medium.jpg",
  "uploadDate" : "2026-07-13T13:46:08.749Z",
  "width" : 1920
}
```